[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368426-105":59,"doc-detail-368426-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","characteristics-treatment-and-survival-of-male-breast-cancer-a-21-year-retrospective-analysis","Characteristics, Treatment, and Survival of Male Breast Cancer - A 21-year Retrospective Analysis","","Male breast cancer is an uncommon malignancy representing a small share of all breast cancer diagnoses. This retrospective study reviewed medical records of male patients treated between 2000 and 2021 at a community academic institute in central Illinois. Patient demographics, tumor characteristics, treatment modalities, recurrence, and survival were assessed, including relationships between epidemiological factors and outcomes with age, stage, grade, and hormone receptor status. Findings support national trends and identify age and stage as key mortality associations.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/characteristics-treatment-and-survival-of-male-breast-cancer-a-21-year-retrospective-analysis/368426/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/characteristics-treatment-and-survival-of-male-breast-cancer-a-21-year-retrospective-analysis/368426.png","ImageObject",300,407,{"name":92,"@type":93},"Jake","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What study design and time span were used?","Question",{"text":112,"@type":113},"The study used a retrospective review of medical records for male patients treated between 2000 and 2021.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What tumor characteristics were most common?",{"text":117,"@type":113},"Most tumors were estrogen receptor-positive (96.1%) and progesterone receptor-positive (93.5%), while HER-2 neu receptor positivity was found in 13.5% of cases.",{"name":119,"@type":110,"acceptedAnswer":120},"How were recurrence and survival outcomes measured?",{"text":121,"@type":113},"Recurrence rates were reported, and survival outcomes included 5-year recurrence-free survival and 5-year overall survival for the cohort.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368426,1790703812,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084928904,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Characteristics, Treatment, and Survival of Male Breast Cancer: A 21-year Retrospective Analysis at a Community Academic Institute in Central Illinois  \nCancer Control Volume 32: 1–11 © The Author(s) 2025 Article reuse guidelines:  \n[sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/10732748251335365](DOI: 10.1177/10732748251335365)  \n[journals.sagepub.com/home/ccx](journals.sagepub.com/home/ccx)  \nWaqas Azhar, MD 1,2, Ricardo Cossyleon, MD, MS 1,2 􀀁, Syeda Fatima Kamal, MD2, Kristin Delﬁno, PhD2, Kathy Robinson, PhD 1,2, and Krishna Rao, PhD 1,2 􀀁  \nAbstract  \nIntroduction: Male breast cancer is an uncommon disease, representing a fraction of all breast cancer diagnoses. This study examines the characteristics, treatment, and outcomes of males with breast cancer at a community academic institute in central Illinois. Methods: We retrospectively reviewed the medical records of male patients with breast cancer treated between 2000 and 2021 . This review focuses on patient demographics, tumor characteristics, treatment modalities, and recurrence and survival rates. We evaluated the association of epidemiological factors and clinical outcomes with patient age, tumor stage, and grade, as well as tumor hormone receptor status.  \nResults: Our study included 81 male patients, predominantly white, with a median age of 67 years. Most cases presented estrogen receptor-positive (96.1%) and progesterone receptor-positive (93.5%) tumors, while only 13.5% had HER-2 neu receptor-positive expression. Staging distribution was 34.6% at Stage I, 47.4% at Stage II, and 17.9% at Stages III/IV among 78 patients. Recurrence occurred in 20.8% of 77 patients, with a 5-year recurrence-free survival rate of 76.2%. The 5-year overall survival rate of all 81 patients was 63.4%. Age and disease stage were signiﬁcantly associated with mortality (P = .041 and P = .0028, respectively). Conclusion: Our ﬁndings align with national trends in male breast cancer demographics and outcomes, with comparable survival statistics. Increased awareness and targeted research are critical to improving management and prognosis for this patient population. Further studies are necessary to elucidate the molecular basis of male breast cancer and to reﬁne treatment guidelines.  \nKeywords  \nmale, breast cancer, central Illinois, mortality, recurrence  \nReceived: 6 December 2024; revised: 20 March 2025; accepted: 27 March 2025.  \nIntroduction  \nBreast cancer, predominantly seen as a female disease, also affects men, though very infrequently. Male breast cancer (MBC) accounts for approximately 1% of all breast cancersand 1% of cancer diagnoses among men globally, representing a unique subset within oncology.1,2 The rarity of MBC has contributed to a signiﬁcant knowledge gap in its pathophysiology, leading to a reliance on data extrapolated from female breast cancer research for treatment protocols.3,4 However, emerging evidence suggests that MBC has  \n1 Division of Hematology and Oncology, Simmons Cancer Institute, SIU School of Medicine, Springﬁeld, IL, USA  \n2Internal Medicine, SIU School of Medicine, Springﬁeld, IL, USA 3Simmons Cancer Institute, SIU School of Medicine, Springﬁeld, IL, USA  \nCorresponding Author:  \nKrishna Rao, Division of Hematology and Oncology, Simmons Cancer Institute, SIU School of Medicine, 315 W Carpenter St, Springﬁeld, IL 62702, USA.  \nEmail: [krao@siumed.edu](krao@siumed.edu)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons  \nAttribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://creativecommons.org/licenses/by-nc/4.0/)) which permits non-commercial use,  \nreproduction and distribution of the work without further permission provided the original work is attributed as speciﬁed on the SAGE and Open Access pages ([https://us.sagepub.com/en-us/nam/open-access-at-sage](https://us.sagepub.","cbCaioC4Z1CjJ4bo","https://ap.wps.com/l/cbCaioC4Z1CjJ4bo","pdf",865726,11,"English","# Abstract\n# Introduction\n# Methodology\n# Results\n# Conclusion","[{\"question\":\"What study design and time span were used?\",\"answer\":\"The study used a retrospective review of medical records for male patients treated between 2000 and 2021.\"},{\"question\":\"What tumor characteristics were most common?\",\"answer\":\"Most tumors were estrogen receptor-positive (96.1%) and progesterone receptor-positive (93.5%), while HER-2 neu receptor positivity was found in 13.5% of cases.\"},{\"question\":\"How were recurrence and survival outcomes measured?\",\"answer\":\"Recurrence rates were reported, and survival outcomes included 5-year recurrence-free survival and 5-year overall survival for the cohort.\"}]","Characteristics, Treatment, and Survival of Male Breast Cancer - A 21-year Retrospective Analysis | PDF",1790176898,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/55fe5c9a40bd9133066f2235d6ac7c6b.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c77c60b0906b458cd44a17c4dd84c15.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3acc345a07e56378213567c983b9cdc3.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aecf1383e89b981b864c5f1540f390b1.webp",980,1268]